Tracheobronchial involvement as a sole manifestation of relapsing polychondritis. 2010

Nimrod Maimon, and Peter Lee, and Narinder Paul, and David Hwang, and Theodore K Marras, and Shaf Keshavjee, and Charles K N Chan
*Division of Respirology, Department of Medicine, University Health Network †Division of Rheumatology, Department of Medicine, Mount-Sinai Hospital Departments of ‡Medical Imaging §Pathology ∥Thoracic Surgery, University Health Network, University of Toronto, Toronto, Canada.

OBJECTIVE To report the clinical, imaging, and pathologic manifestations of case series of patients in whom the only systemic expression of relapsing polychondritis (RP) was their airway complications. METHODS Retrospective review of the medical records of all patients with respiratory complications of RP between 1995 and 2007. METHODS Tertiary care, university-affiliated hospital. RESULTS Three patients with RP had just lower airway manifestations as the only sign of their RP. All 3 were women, aged 44, 49, and 54 years. All had an abnormal chest computed tomography scan, although 2 had a completely normal chest x-ray. All had positive tracheal biopsy, which was consistent with the diagnosis of respiratory chondritis. Pulmonary function tests showed severe reduction in forced expiratory volume in 1 second in all patients. Bronchoscopy revealed tracheal narrowing with variable degrees of inflammation and collapsibility in all patients. Two of the 3 patients underwent tracheal and bronchial stent insertion. Pharmacotherapy included prednisone, methotrexate, cyclophosphamide, and leflunomide. The overall outcome was poor. Two patients died as a result of respiratory complications, 25 and 30 months from diagnoses, and 1 is still alive with follow-up of 85 months after presentation. CONCLUSIONS Lower airway manifestations of RP can be the only sign of the disease. RP has to be considered in the differential diagnosis of patients with recent onset of progressive dyspnea and severe airflow limitation even without other systemic signs of cartilage damage.

UI MeSH Term Description Entries

Related Publications

Nimrod Maimon, and Peter Lee, and Narinder Paul, and David Hwang, and Theodore K Marras, and Shaf Keshavjee, and Charles K N Chan
September 2019, Autoimmunity reviews,
Nimrod Maimon, and Peter Lee, and Narinder Paul, and David Hwang, and Theodore K Marras, and Shaf Keshavjee, and Charles K N Chan
January 2000, Respiration; international review of thoracic diseases,
Nimrod Maimon, and Peter Lee, and Narinder Paul, and David Hwang, and Theodore K Marras, and Shaf Keshavjee, and Charles K N Chan
June 2005, Journal of the Chinese Medical Association : JCMA,
Nimrod Maimon, and Peter Lee, and Narinder Paul, and David Hwang, and Theodore K Marras, and Shaf Keshavjee, and Charles K N Chan
January 1988, Journal of computer assisted tomography,
Nimrod Maimon, and Peter Lee, and Narinder Paul, and David Hwang, and Theodore K Marras, and Shaf Keshavjee, and Charles K N Chan
May 2024, Revue des maladies respiratoires,
Nimrod Maimon, and Peter Lee, and Narinder Paul, and David Hwang, and Theodore K Marras, and Shaf Keshavjee, and Charles K N Chan
January 2013, Internal medicine (Tokyo, Japan),
Nimrod Maimon, and Peter Lee, and Narinder Paul, and David Hwang, and Theodore K Marras, and Shaf Keshavjee, and Charles K N Chan
August 2019, Arthritis & rheumatology (Hoboken, N.J.),
Nimrod Maimon, and Peter Lee, and Narinder Paul, and David Hwang, and Theodore K Marras, and Shaf Keshavjee, and Charles K N Chan
February 1994, Italian journal of neurological sciences,
Nimrod Maimon, and Peter Lee, and Narinder Paul, and David Hwang, and Theodore K Marras, and Shaf Keshavjee, and Charles K N Chan
October 1998, Annals of the rheumatic diseases,
Nimrod Maimon, and Peter Lee, and Narinder Paul, and David Hwang, and Theodore K Marras, and Shaf Keshavjee, and Charles K N Chan
July 2022, World journal of clinical cases,
Copied contents to your clipboard!